Introduction
We are doctors looking after patients with blood disorders and scientists studying blood conditions in the lab. Our aim is to deliver the best expert and compassionate care for patients with blood diseases and patients who need blood cell transfusions. We want to reduce the burden of disease now and in the future, through our research, services, education, outreach and advocacy.
Our group includes international, scientific and clinical leaders. We draw on our combined expertise to carry out research and develop new services. Through our work we aim to:
- Improve the cost-effectiveness of cancer therapies and the outcomes of treatment – by developing new single cell approaches which tailor treatments to individuals. Find out more
- Improve the management of common and rare anaemias – by studying the role of iron and inflammation in anaemic patients, especially those who are elderly, and by developing a new national NHS service for patients with rare inherited red cell disorders. Find out more
- Improve the outcomes of blood cell and blood component transfusions – by using advanced e-tools and carrying out clinical trials to find out what approaches work best. Find out more
- Involve patients and carers in the key steps of our research projects. Find out more
Related websites
Oxford Centre for Haematology website: rdm.ox.ac.uk/och
RDM – HaemBio Biobank pages:
rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/och/haembio
NSSG website: nssg.oxford-haematology.org.uk
Introductory Talk by Haematology and Stem Cells Theme Lead Professor Paresh Vyas
Follow the Oxford Centre for Haematology on Twitter
Update on RomiCar, CI @graham74GC, a combination trial on peripheral T-cell lymphoma, which can be particularly difficult to treat
#trialfocus - RomiCar
Ph I/II romidepsin + carfilzomib in rel T-cell NHL.
- CI - @graham74GC
- Fully recruited
- top recruiter @CwynKate
- @bloodwise_uk TAP study
- clinical data pending
- great example of where CRM design helped recruit to study
@OxfordOncology @OxfordHaem
Want to help shape the strategic direction of the Sickle Cell Society? Then apply to be on our board of trustees. Find out more and apply here: #Volunteer #Trustee #SickleCell
Trustee Vacancy » Sickle Cell Society
Trustee Vacancy: We are looking to recruit two trustees to help shape the strategic direction of the Society, building on excellent progress made so.....
www.sicklecellsociety.org
Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study
Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study
BACKGROUND Anemia is common in critically ill patients and associated with adverse outcomes. Phlebotomy associated with laboratory testing is a potent...
onlinelibrary.wiley.com
Gene therapy beneficial for haemophilia A. Long-term follow up of patients who received gene therapy for severe haemophilia A has found a beneficial effect on bleeding events and removed the need for factor VIII supplementation. https://t.co/BU3eEE7Zt7
@EPCTU_Oxford - Twitter accout just opened and I have the password....! Do follow.
A terrific early phase unit run by @sarah_blagden. Committed team delivering early phase trials. Seamless integration of oncology and haematology. Privilege to be part of it.
@OUH_Research
